AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Uber earnings + using AI to revolutionize clinical trials w/ Unlearn.AI’s Charles Fisher | E1734
This Week in Startups
The Criticisms of the Phase Three Clinical Trial Process
2min Snip
00:00
Summary
Transcript
Episode notes
The majority of time, actually only about 10% of drugs that enter clinical trials end up being successful. So you're spending like a decade in hundreds of millions of dollars on an experiment with a 90% failure rate. And would that mean if one out of 10 actually work, we're talking about billions of dollars to get a successful drug to market? That's right. Got it. What are the criticisms of that process? And then we'll get on to what you're doing.
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode